BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.79M | 12.26M | 11.16M | 9.85M | 9.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.55M | 32.31M | 29.58M | 25.18M | 25.35M |
| Operating Income | -35.55M | -32.31M | -29.58M | -25.18M | -25.35M |
| Income Before Tax | -17.71M | -8.69M | -26.23M | -37.11M | -26.15M |
| Income Tax Expenses | 13.00K | 11.00K | 19.00K | 22.00K | 23.00K |
| Earnings from Continuing Operations | -17.73 | -8.71 | -26.25 | -37.14 | -26.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.73M | -8.71M | -26.25M | -37.14M | -26.17M |
| EBIT | -35.55M | -32.31M | -29.58M | -25.18M | -25.35M |
| EBITDA | -33.75M | -31.22M | -28.59M | -24.31M | -24.48M |
| EPS Basic | -1.94 | -2.05 | -3.66 | -5.67 | -5.43 |
| Normalized Basic EPS | -1.33 | -1.68 | -2.89 | -3.82 | -3.39 |
| EPS Diluted | -4.63 | -4.65 | -6.26 | -5.67 | -5.43 |
| Normalized Diluted EPS | -1.41 | -1.76 | -2.97 | -3.82 | -3.39 |
| Average Basic Shares Outstanding | 48.08M | 35.91M | 25.60M | 23.52M | 20.50M |
| Average Diluted Shares Outstanding | 55.90M | 43.73M | 33.40M | 23.52M | 20.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |